Term information
- EFO:0000616
- ICD9:239.8
- NCIT:C3262
- HP:0002664
- ONCOTREE:OTHER
- MESH:D009369
- UMLS:CN236628
- SCTID:55342001
- ICD9:239.9
- COHD:438112
- ICD9:140-239.99
- DOID:14566
- ICD10:C00.D48
http://purl.obolibrary.org/obo/NCIT_C17649
http://identifiers.org/snomedct/108369006
http://linkedlifedata.com/resource/umls/id/C0205394
http://linkedlifedata.com/resource/umls/id/C0375111
A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.
http://linkedlifedata.com/resource/umls/id/CN236628
http://identifiers.org/mesh/D009369
http://identifiers.org/snomedct/55342001
http://purl.obolibrary.org/obo/DOID_14566
neoplastic growth
neoplastic disease
tumor
neoplasm
disease of cellular proliferation
tumor disease
neoplasia
Epileptogenic tumors are, in the majority, biologically benign lesions that do not usually change over time. As a result, they do not require oncological surgery and surveillance, instead their management centres on control of seizures. Some tumors are highly associated with refractory epilepsy, and are amenable to epilepsy surgery due to their anatomic and imaging features, epilepsy surgery is therefore an important treatment option for this group of patients.